The aim of current study was the application of validated TLC-densitometric method for identification and determination of Estradiol hemihydrate in dosage forms. The applied TLC conditions were: Silicagel G 60 F 254 glass plates; mobile phase: chloroform : acetone = 90 : 10 v/v, migration distance of mobile phase: 120 mm, UV-detection at  = 254 nm. All of the experimental results for the content of Estradiol hemihydrate correspond to the respective confidence interval: Estrofem 
INTRODUCTION
Osteoporosis is designated as the third socially significant disease in the world, after cardiovascular and oncological diseases and the forecast is to take second place in 2020. Osteoporosis is caused by the reduced levels of estrogen, which in postmenopausal women are 1/10 of the levels in premenopausal women. 2 Lowered levels of estrogen lead to: 1) increase of oxidative stress; 2) apoptosis of osteoblasts; 3) rapid loss of bone mass due to increased rate of degradation of the bone tissue by osteoclasts; 4) a long life of osteoclasts compared to osteoblasts; 5) reduction of the absorption and utilization of calcium in bones. 3 Most pharmacological agents used in the prevention and treatment of osteoporosis reduce bone resor ption or delay the total rate of bone turnover. For the prevention of fractures are applied: inhibitors of the activity of osteoclastsbisphosphonates Rizedronate and Zoledronate, 4 selective estrogen receptor modulators Bazedoxifene 5 and Lasofoxifene 6 parathyroid hormone, 7 Strontium ranelate 8 and antiresorptive agent Denosumab -a human monoclonal antibody IgG 2 .
9 Bisphosphonates cause adverse effects on gastrointestinal tract 10 : nausea, heartburn, scleritis and iritis (Alendronate). 11 Selective estrogen receptor modulators Bazedoxifene 12 and Raloxifene 13 reduce resorption activity by inhibition of the production of interleukin 6, tumor necrosis factor α and the number of osteoclasts. Preclinical studies indicate that Strontium ranelate has a dual mechanism of action: 1) induces the bone formation by synthesis of bone collagen, alkaline phosphatase and osteocalcin; 2) inhibits the osteoclastogenesis by suppressing the differentiation and activity of osteoclasts. Hormonal therapy reduces the risk of osteoporotic fractures and improves the bone mineral density. 15, 16 Several methods have been reported for the determination of 17βEstradiol: UVspectrophotometry, high performance liquid chromatography (HPLC) 17 thin layer chromatography (TLC) 18 and voltametry. 19 Literature review reveals that HPLC methods are very often applied for the estimation of Estradiol hemihydrate.
17
For the quantification of 17βEstradiol alone or in combinations in different pharmaceutical preparations are developed the following methods: I) TLC on Silicagel G 60 F 254 , mobile phase: benzol : methanol = 9 : 1 v/v: 18 17βEstradiol; II) RPHPLC with UV-detection: 1) column Phenomenex C 18 (4.6 mm x 250 mm x 5 μm), mobile phase: methanol : water = 70 : 30 v/v, flow rate: 1.0 ml/min., λ = 281 nm, 17 2) 17βЕstradiol, Еstriol and Еstronе: column С 18 micro Bondapak, isocratic mode, mobile phase: acetonitrile : water = 50 : 50 v/v, flow rate: 1 ml/min., column temperature: 30 o С, λ = 205 nm, 20 3) 17βEstradiol and its degradation products in Estrogel: column Zorbax SBCN (4.6 mm x 150 mm x 5 μm), mobile phase: acetonitrile : 0.085% phosphoric acid : tetrahydrofurane = 27 : 63 : 10 v/v, flow rate: 1.0 ml/min., λ = 225 nm, 21 4) 17βEstradiol and Еstrone in Estrogel: column Supelco Discovery С 18 (250 mm х 3.0 mm), mobile phase: acetonitrile : methanol : water = 23 : 24 : 53 v/v, flow rate: 0.9 ml/min., λ = 225 nm, 22 III) HPLC with fluorimetric detection: 17β-Еstradiol and Еstriol at λexcitation = 280 nm and λеmission = 312 nm, 23 IV) NPHPLC with mas detection with atmospheric pressure photoionization, 24 V) fluorimetry after derivatization reaction with dansylchloride, 25 VI) electrochemical methods with: 1) glass carbon electrode, modified with electropolymerized pyrrole, 26 2) poly(Lserine)film modified electrode, 27 3) linear sweep voltammetry. 28 In our previous work TLCdensitometric method was validated in accordance with analytical parameters: linearity, limit of detection (LOD), limit of quantitation (LOQ), accuracy and precission (repeatability). 29 The aim of current study was the application of the validated TLC densitometric method for identification and determination of Estradiol hemihydrate in dosage forms.
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METHODS
TLC-densitometry
Instrumentation: Densitometer VILBER LOURMAT CN15.LC Serial: 16263; sample applicator 10 ml micropipette (Hamilton, Bonaduz, Switzerland, N:18005701); TLC glass chamber (22 cm x 12 cm x 22 cm); stationary phase: TLC glass plates, 20 cm x 20 cm (Sigma Aldrich, N: 2364681) were used. Chromatographic conditions: stationary phase: TLC glass plates precoated with Silicagel G 60 F 254 , mobile phase: chloroform : acetone = 90 : 10 v/v, migration distance of mobile phase: 120 mm, UV-detection at l = 254 nm.
Preparation of test solutions from dosage formulations (tablets), containing Estradiol hemihydrate for the investigation of analytical parameter precision (repeatability)
Separately from every drug formulation 20 tablets were weighed accurately. From homogenous powdered tablets from every drug preparation on an analytical balance accuratelly were weighed 6 samples, containing an amount equivalent respectively to 10 mg (Trisequence T3 Every sample was transferred separately to a 10.0 ml volumetric flask and was diluted with 99.98% ethanol. The solutions were filtered through a blue band filter and were analyzed by the densitometric method described. Chromatographic procedure: Chromatographic analysis was achieved by using glass TLC plates. From every solution separatelly were spotted aliquot parts of 10 ml onto glass plates Silicagel G 60 F 254 , keeping 10 mm 5.10 4 g/ml ÷ 5.10 3 g/ml was proved by the regression equation: y = 53256970.x -7007 (y -peak area, xconcentration of analyte). The least squares regression yielded a correlation coefficient R = 0.994. Limit of detection and limit of quantitation were determined based on the standard deviation of the response and the slope of the regression equation for the calibration curve. The limit of detection, defined the concentration giving a signal with signal to noise ratio of 3, was 3.91. 10 4 g/ml. The limit of quantitation, defined the concentration giving a signal with signal to noise ratio of 10, was 1.18.10 3 g/ml. For the estimation of analytical parameter accuracy the recovery study was carried out by application of the method in triplicate to every to 3 different model mixtures, containing known amount of Estradiol hemihydrate: 75%, (1.5 mg, С 1.5 ); 100% (2 mg, С 2 ); 125% (2.5 mg, С 2.5 ). The content of drug in model mixtures was determined by method of calibration curve using the regression equation. For the assessment of accuracy and precision was calculated sample standard deviation (SD), by the applying of the Bessel's correction, in which the denominator N−1 (degrees of freedom) is used instead of N and in this case (S) 2 is an unbiased estimator for (SD). 2 The results for accuracy at P = 90 % (t = 2.92), presented by the degree recovery R (%) ± RSD (%) suit respective confidence interval: 1) RС 1.5 : 98.75 % ÷ 102.13 % (SD = 1.01); 2) RС 2 : 98.73 % ÷ 102.93 % (SD = 1.25); 3) RС 2.5 : 98.29 % ÷ 103.03 % (SD = 1.4). For the estimation of an analytical para meter precision (repeatability) was used the uncertainty of the result, which was determined by: standard deviation (SD), relative standard deviation (RSD) and confidence range. All data for the obtained quantity of Estradiol hemihydrate correspond to the confidence interval: 1.95 mg ÷ 2.09 mg (SD = 0.05). 29 In current study the indentity of Estradiol hemihydrate in analysed drug formulations was proved by the correspondence between the retardation factors of drug in samples and reference standard Rf = 0.65. (Table 1) . For the assessment of the need for the removal of sharply differing data is used the criterion of Chauvent. From Table 2 . it is obvious that for all of the analysed tablets the calculated Chauvenet's criterion for the area of the spots (UA) and for the quantities (UC) of Estradiol hemihydrate are lower than the maximum value of the criterion (Umax = 1.73; N = 6), which proves that the results suit to the requirements of the criterion for the analysis of 6 separate samples from Estrofem Table 3 . are presented the data for: N -number of individual measurements (1  6); X -mean arithmetic distance between bands. The plate was developed about at 25 ± 1 o C in ascending vertical manner in glass chromatographic chamber, previously presaturated for 1 h with mobile phase: chloroform: acetone = 90 : 10 v/v. The migration distance of the mobile phase in all experi ments was 120 mm. The developed plates were dried on air. Densitometric scanning was performed on scanner VILBER LOURMAT CN15 LC, operated in the absorbance mode at λ = 254 nm.
RESULTS
In recent work the validated TLCdensitometric method was applied for identification and determination of Estradiol hemihydrate in dosage pharmaceutical formulations-tablets. The obtained by TLCdensitometric method chromatograms of tablets were presented as follows: Estrofem 
DISCUSSION
In our previous work a TLCdensitometric method was validated in accordance with International Conference on Harmonization guidelines for validation of analytical procedures for analytical parameters: limearity, LOD, LOQ, accuracy and precission (repeatability). 30 Placebo solution, containing as supplement starch, without the active substance Estradiol hemihydrate was prepared. The selectivity of the applied method was confirmed by the fact that on chromatogram with placebo preparation did not exist spot with Rf, corresponding to Rf of Estradiol hemihydrate (0.66) in reference standard solution. This fact confirms that there was no interference from the commonly present in tablets excipient starch. The calibration curve was obtained by using the data for different concentrations of standard solutions of Estradiol hemihydrate and was generated by plotting the sample concentration versus the mean peak area. Linear regression analysis was performed. Linearity accordance between the concentration and spot area in range: Estrofem table, Femoston table and Trisequens table   N:  Estrofem table  Femoston F1 table  Femoston F2 error; SD -standard deviation; RSD -relative standard deviation (%); S X -mean square error; X ± t.S X = X -t.S X + t.S X -confidence interval; E (%) -relative error. The used values for confidence possibility was P = 95 % and for coefficient of Student: t = 2.57.
CONCLUSION
The validated TLCdensitometric method was applied for the identification and determination of Estradiol hemihydrate in tablets. The analytical parameter repeatability for the content of Estradiol hemihydrate in tablets was characterized with SD and RSD. The results showed that all of the obtained by method of calibration curve experimental results for the content of Estradiol hemihydrate correspond to the respective confidence interval. The proposed validated TLCdensitometric method is appropriate for quality control of Estradiol hemihydrate in commercially available tablets.
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SUMMARY
• The aim of current study was the application of validated TLC-densitometric method for identification and determination of Estradiol hemihydrate in dosage forms.
• The applied TLC conditions were: Silicagel G 60 F 254 glass plates; mobile phase: chloroform : acetone = 90 : 10 v/v, migration distance of mobile phase: 120 mm, UV-detection at λ = 254 nm.
• The indentity of Estradiol hemihydrate in analysed drug formulations was proved by the correspondence between the retardation factors of drug in samples and reference standard.
• The content of Estradiol hemihydrate in tablets was determined by method of calibration curve using the regression equation.
• For the estimation of an analytical parameter precision (repeatability) was used the uncertainty of the result, which was determined by: standard deviation (SD), relative standard deviation (RSD) and confidence range.
• All of the experimental results for the content of Estradiol hemihydrate correspond to the respective confidence interval: Estrofem 
